Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients can be included in the study if they meet all of the criteria below: 1. Current smoker (has smoked in the 7 days prior to randomisation date) 2. Able to read English and can provide written informed consent 3. Is seriously considering quitting smoking and is willing to set a quit date within the 14 days after randomisation 4. Aged 18 - 75 years, either sex 5. Has a mobile phone and is familiar with sending and receiving SMS text messages 6. Is willing to participate in study and follow study procedures 7. Is not currently enrolled in another formal smoking cessation study or program 8. Is not using nicotene replacement therapy (NRT), bupropion (Zyban®) and varenicline (Champix®) or other pharmacotherapy at randomisation date
Exclusion criteria
Exclusion criteria: 1. Do not meet all of the inclusion criteria 2. Considered by their GP to be unsuitable for the project for any reason e.g. people with severe mental impairment or severely or terminally ill Co-morbidities, for example chronic obstructive pulmonary disease (COPD), diabetes, are not excluded from the study (unless their GP considers them unsuitable). In addition, we would not exclude entry to the trial of more than one participant per household, however, should this occur, they would be assigned to the same treatment group (to minimise the potential for contamination).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported effectiveness, using a self report of being abstinent from smoking for at least 2 weeks, at 8-week follow-up from randomisation date, as assessed by postal questionnaire or telephone interview (blinded interviewer). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Carbon monoxide (CO)-verified self-report of being abstinent from smoking for at least 2 weeks, at 4-week follow-up from quit date 2. Self-reported prolonged abstinence (at least 3 months) at 6-month follow-up from randomisation date | — |
Countries
United Kingdom